SCA
DPLO

Southpoint Capital Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Southpoint Capital Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-60,000
Closed -$2.1M – 35
2016
Q2 		$2.1M Hold
60,000
– – 0.11% 26
2016
Q1 		$1.64M Buy
+60,000
New +$1.77M 0.08% 28

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Southpoint Capital Advisors's DPLO Position: Q3 2016 in Review

Southpoint Capital Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2016, closing a stake of 60,000 shares — an estimated $2.1M sold.

Southpoint Capital Advisors first reported a position in DPLO in Q1 2016 and held it in 2 quarters. The position peaked at $2.1M in Q2 2016. 185 funds tracked by Wall St. Rank hold DPLO as of Q3 2016.

  • Southpoint Capital Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2016 after selling out during the quarter.
  • Southpoint Capital Advisors sold 60,000 DIPLOMAT PHARMACY, INC. shares in Q3 2016, an estimated $2.1M.
  • Southpoint Capital Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2016 and held it in 2 quarters.
  • Southpoint Capital Advisors's DIPLOMAT PHARMACY, INC. position peaked at $2.1M in Q2 2016.
  • 185 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2016.

Based on Southpoint Capital Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.